As of April 3, 2026, Heartbeam Inc. (BEAT), a developer of remote cardiac diagnostic and monitoring solutions, trades at a current price of $1.18, marking a 3.28% decline in intraday trading. This analysis focuses on key technical levels, recent market context, and potential near-term trading scenarios for the stock, as no recent earnings data has been released to drive fundamental sentiment as of this writing. Over recent weeks, BEAT has traded in a relatively tight range, with technical suppor
BEAT Stock Analysis: Heartbeam Inc. drops 3.28% to $1.18 testing key short-term support
BEAT - Stock Analysis
3793 Comments
729 Likes
1
Dessence
Engaged Reader
2 hours ago
This kind of delay always costs something.
👍 23
Reply
2
Lianette
New Visitor
5 hours ago
Well-explained trends, makes complex topics understandable.
👍 163
Reply
3
Kohani
Returning User
1 day ago
This would’ve been really useful earlier today.
👍 119
Reply
4
Azryah
Regular Reader
1 day ago
I guess I learned something… just late.
👍 89
Reply
5
Chantail
New Visitor
2 days ago
Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
👍 247
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.